Isabelle Melki

10.1k total citations
69 papers, 875 citations indexed

About

Isabelle Melki is a scholar working on Molecular Biology, Rheumatology and Surgery. According to data from OpenAlex, Isabelle Melki has authored 69 papers receiving a total of 875 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 20 papers in Rheumatology and 17 papers in Surgery. Recurrent topics in Isabelle Melki's work include Inflammasome and immune disorders (18 papers), Kawasaki Disease and Coronary Complications (13 papers) and Autoimmune and Inflammatory Disorders Research (12 papers). Isabelle Melki is often cited by papers focused on Inflammasome and immune disorders (18 papers), Kawasaki Disease and Coronary Complications (13 papers) and Autoimmune and Inflammatory Disorders Research (12 papers). Isabelle Melki collaborates with scholars based in France, Switzerland and United Kingdom. Isabelle Melki's co-authors include Brigitte Bader‐Meunier, Pierre Quartier, Marie‐Louise Frémond, Yanick J. Crow, Christine Bodemer, Ulrich Meinzer, Albert Faye, Mathieu P. Rodero, Alexandre Bélot and Constance Beyler and has published in prestigious journals such as Annals of Internal Medicine, PEDIATRICS and Journal of Allergy and Clinical Immunology.

In The Last Decade

Isabelle Melki

59 papers receiving 861 citations

Peers

Countries citing papers authored by Isabelle Melki

Since Specialization

Citations

This map shows the geographic impact of Isabelle Melki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Melki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Melki more than expected).

Fields of papers citing papers by Isabelle Melki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabelle Melki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Melki. The network helps show where Isabelle Melki may publish in the future.

Co-authorship network of co-authors of Isabelle Melki

This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle Melki. A scholar is included among the top collaborators of Isabelle Melki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle Melki. Isabelle Melki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	French protocol for the diagnosis and management of juvenile idiopathic arthritis including pediatric-onset Still's disease 2025 ·La Revue de Médecine Interne ·Pierre Quartier, Alexandre Bélot, Sylvain Breton, Aurélia Carbasse, Valérie Devauchelle, Bruno Fautrel, Sophie Georgin-Lavialle, (unknown), Isabelle Koné‐Paut, I. Lemelle, Ulrich Meinzer, Isabelle Melki, Pascal Pillet, Héloïse Reumaux, (unknown), Florence Uettwiller, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	0
2	French protocol for diagnosis and management of type 1 interferonopathies 2025 ·La Revue de Médecine Interne ·Alexandre Bélot, Odile Boespflug‐Tanguy, Guilaine Boursier, Marie Hully, Bénédicte Neven, Florence Renaldo, Héloïse Reumaux, Sébastien Viel, Marie‐Louise Frémond, Isabelle Melki, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	0
3	Common Seasonal Pathogens and Epidemiology of Henoch-Schönlein Purpura Among Children 2024 ·JAMA Network Open ·A. Felix, Zein Assad, Philippe Bidet, Marion Caséris, Cécile Dumaine, Albert Faye, Isabelle Melki, Florentia Kaguelidou, (unknown), Naïm Ouldali, Ulrich Meinzer	8
4	Transition to Adult Care in Autoinflammatory Diseases 2024 ·JCR Journal of Clinical Rheumatology ·(unknown), Véronique Hentgen, Pierre Quartier, Brigitte Bader‐Meunier, Isabelle Koné‐Paut, Bénédicte Neven, Linda Rossi‐Semerano, (unknown), Ulrich Meinzer, Isabelle Melki, Gilles Grateau, Léa Savey, Sophie Georgin‐Lavialle	1
5	The place of JAK inhibitors in systemic juvenile idiopathic arthritis with lung disease: French experience 2024 ·Lara D. Veeken ·(unknown), Pierre Quartier, Alexandre Bélot, Isabelle Melki, Véronique Hentgen, Étienne Merlin	0
6	Diagnostic delays in familial Mediterranean fever: a Juvenile Inflammatory Rheumatism (JIR) cohort study 2024 ·Rheumatology International ·R. Bourguiba, Samuel Deshayes, Gayane Amaryan, Isabelle Koné‐Paut, Alexandre Bélot, (unknown), (unknown), (unknown), Isabelle Melki, Ulrich Meinzer, (unknown), N. Schleinitz, Véronique Hentgen, Sophie Georgin‐Lavialle	0
7	OP0036 FREQUENCY AND FACTORS ASSOCIATED WITH DIAGNOSTIC DELAY IN EUROPEAN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER: A STUDY ON 960 PATIENTS FROM THE JIR COHORT 2023 ·R. Bourguiba, Samuel Deshayes, Gayane Amaryan, Isabelle Koné‐Paut, Alexandre Bélot, (unknown), (unknown), Michaël Hofer, Jana Pachlopnik Schmid, Isabelle Melki, Ulrich Meinzer, Diana Dan, N. Schleinitz, Véronique Hentgen, Sophie Georgin‐Lavialle	1
8	Assessment of type I interferon response in routine practice in France in 2022 2023 ·RMD Open ·(unknown), Anne‐Perrine Foray, Lorna Garnier, Christine Lombard, É. Hachulla, Brigitte Bader‐Meunier, Sophie Georgin‐Lavialle, Isabelle Melki, Thierry Walzer, Alexandre Bélot, Sébastien Viel	8
9	JAK Inhibition in Juvenile Idiopathic Arthritis (JIA): Better Understanding of a Promising Therapy for Refractory Cases 2023 ·Journal of Clinical Medicine ·Isabelle Melki, Marie‐Louise Frémond	6
10	Osteonecrosis in patients with juvenile dermatomyositis: is it associated with anti-MDA5 autoantibody? 2023 ·Lara D. Veeken ·Brigitte Bader‐Meunier, Sylvain Breton, Darragh Duffy, Cyril Gitiaux, Pierre Quartier, I. Lemelle, Alain Meyer, (unknown), Marie‐Louise Frémond, Jean‐Luc Charuel, Mathieu P. Rodero, Isabelle Melki	1
11	Outcome of COVID-19 in patients with rheumatic and inflammatory diseases treated with mycophenolic acid: data from the French RMD COVID-19 cohort 2022 ·RMD Open ·Marie‐Elise Truchetet, Élodie Drumez, Thomas Barnetche, Claire Martin, Mathilde Devaux, Tiphaine Goulenok, (unknown), J. Schmidt, (unknown), Isabelle Melki, É. Hachulla, Christophe Richez	2
12	Acute bronchiolitis: Experience of home oxygen therapy in “Hospital at Home” care from 2012 to 2014 2022 ·Archives de Pédiatrie ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Isabelle Melki, Bérengère Koehl, C. Lemaître, (unknown), Albert Faye, Mathie Lorrot	1
13	Mevalonate Kinase Deficiency: A Cause of Severe Very-Early-Onset Inflammatory Bowel Disease 2021 ·Inflammatory Bowel Diseases ·Brigitte Bader‐Meunier, (unknown), Fabienne Charbit‐Henrion, Ulrich Meinzer, Alexandre Bélot, Laurence Cuisset, Albert Faye, Sophie Georgin‐Lavialle, Pierre Quartier, (unknown), Frank M. Ruemmele, Florence Uettwiller, Jérôme Viala, Nadine Cerf–Bensussan, Dominique Berrebi, Isabelle Melki	8
14	JAK inhibitors are effective in a subset of patients with juvenile dermatomyositis: a monocentric retrospective study 2021 ·Lara D. Veeken ·Tom Le Voyer, Cyril Gitiaux, François‐Jérôme Authier, Christine Bodemer, Isabelle Melki, Pierre Quartier, Florence A. Aeschlimann, Arnaud Isapof, Jean‐Philippe Herbeuval, Vincent Bondet, Jean‐Luc Charuel, Marie‐Louise Frémond, Darragh Duffy, Mathieu P. Rodero, Brigitte Bader‐Meunier	54
15	LC-MS/MS Identification of Prolidase Deficiency: A Rare Cause of Infantile Hepatosplenomegaly 2021 ·Clinical Chemistry ·(unknown), Dimitri Schlemmer, Juliette Bouchereau, (unknown), Samia Pichard, E. Bourrat, Isabelle Melki, Manuel Schiff, Jean‐François Benoist, Apolline Imbard	2
16	From Diagnosis to Prognosis: Revisiting the Meaning of Muscle ISG15 Overexpression in Juvenile Inflammatory Myopathies 2020 ·Arthritis & Rheumatology ·(unknown), (unknown), (unknown), Christine Barnérias, Christine Bodemer, Isabelle Desguerre, Pierre Quartier, Isabelle Melki, Gillian Rice, Mathieu P. Rodero, Jean‐Luc Charuel, Frédéric Relaix, Brigitte Bader‐Meunier, François‐Jérôme Authier, Cyril Gitiaux	14
17	Clinical features of children with enthesitis-related juvenile idiopathic arthritis / juvenile spondyloarthritis followed in a French tertiary care pediatric rheumatology centre 2018 ·Pediatric Rheumatology ·(unknown), Sylvain Breton, (unknown), (unknown), Florence Uettwiller, Isabelle Melki, Richard Mouy, Carine Wouters, Brigitte Bader‐Meunier, C Job-Deslandre, Pierre Quartier	36
18	Etanercept concentration and immunogenicity do not influence the response to Etanercept in patients with juvenile idiopathic arthritis 2018 ·Seminars in Arthritis and Rheumatism ·Brigitte Bader‐Meunier, Roman Krzysiek, I. Lemelle, (unknown), Aurélia Carbasse, Sylvaine Poignant, Isabelle Melki, Pierre Quartier, Laure Choupeaux, (unknown), Jean‐Marc Tréluyer, Alexandre Bélot, Salima Hacein‐Bey‐Abina, Saı̈k Urien	8
19	Novel monogenic diseases causing human autoimmunity 2015 ·Current Opinion in Immunology ·Isabelle Melki, Yanick J. Crow	14
20	Mutation in the SLC29A3 Gene: A New Cause of a Monogenic, Autoinflammatory Condition 2013 ·PEDIATRICS ·Isabelle Melki, Karen Lambot, Laurence Jonard, Vincent Couloigner, Pierre Quartier, Bénédicte Neven, Brigitte Bader‐Meunier	55

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact